Pharmaceutical Technology5h
Risk adjusted net present value: What is the current valuation of Philogen’s Nidlegy?
Nidlegy is a fusion protein commercialized by Philogen, with a leading Phase III program in Metastatic Melanoma.
Pharmaceutical Technology5h
Risk adjusted net present value: What is the current valuation of Philogen’s Fibromun?
Fibromun is a fusion protein commercialized by Philogen, with a leading Phase III program in Soft Tissue Sarcoma.